Article and Video CATEGORIES
We are very excited to launch a new program for GRACE
Patient Perspectives: Clinical Trials Experiences Through Storytelling
**Please Note -- We have extended the deadline for applications to Friday, March 19, 2021. Don't delay!! fill out the application today!
We are inviting all cancer patients with experience in clinical trials (no matter how large or small) to join us in this new program giving voice to the clinical trials experience.
Through storytelling and sharing their experience, patients can educate others who are considering a clinical trial about this part of the cancer journey. All cancer patients currently enrolled in or with past enrollment in a clinical trial are welcomed and encouraged to apply.
Patients selected to participate in this year's program will work closely with GRACE to develop new educational content for patients across a range of platforms that will help them to become established contributors in the area of advocacy. Participants will receive training on digitally distributed content and social media, and their work will be highlighted and shared by GRACE, along with its network of established leaders in the oncology community and board members with an array of interests and connections. Participants will receive a stipend, training in communication and media platforms, and a tech 'package'. Participants will work with GRACE to develop program formats and production and will present a proposal based on their area of experience in a clinical trial program.
For more information, please take a look at and complete our online Program Form and Application, or download the .pdf version available above, which can be emailed as an attachment to dbrock@cancerGRACE.org. If you have questions please contact Denise Brock, Operations Director for GRACE at dbrock@cancerGRACE.org.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…